Frequently Asked Questions: Ozempic and Tirzepatide in Aesthetic Medicine Only when prescribed by trained physicians
21 But now we are seeing hard evidence that may make covering GLP-1s a more palatable call
The deal aimed to strengthen Roche's position in the competitive and growing obesity drug market
Losing weight is an emotional, physical, and personal challenge that goes beyond just diet and exercise For many, it's tied to medical conditions that make traditional methods less effective
[25] It provides a more stable, long-term picture of glycemic control, indicating that statistically, the HbA1c number offers more signal and less noise than an instantaneous reading
As America's trusted leader in GLP-1 weight loss, we understand the unique challenges patients face during their journey